Advance Access published July 14, 2004

Similar documents
Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae

Interactions between components of the essential oil of Melaleuca alternifolia

EcoHydra Antimicrobial Hand Lotion. Product Overview. Physical Properties. Product Description. Regulatory Compliance. Key Features and Benefits

Bacterial smear and Staining

Basic Microbiology and Immunology Practical Course

Antifungal Activity of Tea Tree Oil In Vitro

(Maiden & Betche) Cheel Myrtaceae. Melaleuca alternifolia. LOCAL NAMES English (tea tree oil,narrow-leaved paperbark)

The Effectiveness of Water, Sodium Hypochlorite Bleach, and Peroxyacetic Acid (PAA) in Eradicating Listeria monocytogenes

Jake Rocchi CCHS, 9 th grade 1 st year in PJAS. Bleach Effects on Microbial Life

INVITRO ACTIVITIES OF MELALEUCA ALTERNIFOLIA(TEA TREE OIL) AGAINST VARIOUS ORAL CANDIDA SPECIES - A PILOT STUDY

Survey of the Antimicrobial Activity of Commercially Available Australian Tea Tree (Melaleuca alternifolia) Essential Oil Products In Vitro

LAB 3 CHARACTERIZING YOUR UNKNOWN BACTERIA AND USING MORE COMPLEX STAINS. Part I: Isolating Your Unknown Bacteria and Describing Colony Morphology

Colin M c Steen Pittsburgh Central Catholic High School Grade 9

Sinthia Kabir Mumu, M. Mahboob Hossain *

Topical Skin Care L O O K, F E E L A N D L I V E B E T T E R

AneStop Prensentation

Antimicrobial properties of tea tree oil

COMPARATIVE EFFICACY OF TEA TREE OIL NANOEMULGEL AND TEA TREE OIL GEL AGAINST CANDIDA ALBICANS.

Antifungal activity of tea tree oil

Transforming The Face Of Preservation: Peptide Technology In The Personal Care Industry Antimicrobials A Natural Approach to Product Preservation

Chlorhexidine Gluconate Antimicrobial Skin Cleansers TECHNICAL DATA

Matthew Pilewski Grade 9 Central Catholic High School

THE SURVIVAL AND GROWTH OF MICROORGANISMS IN MASCARA DURING USE Louis A. WILSON, M.D., A. J. JULIAN, M.S., AND DONALD G. AHEARN, PH.D.

DECON-HAND. Instant Hand Sanitizer. HAND_VL Revised 19 November, Technical Data File

VisPRO 5 Minutes Protein Stain Kit

Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties

In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts

OxyBAC. Antimicrobial rich-cream foam hand wash. Kills % of many common germs

Microbiology Department, United Hospitals Trust, Antrim, BT41, UK

Although clindamycin phosphate is inactive in vitro, rapid in vivo hydrolysis converts this compound to the

Bronson & Jacobs and Maria River. Improved Identification Methods for Australian Tea Tree Oil

Center for Food Safety, University of Georgia, Griffin, Georgia Georgia-Pacific Corporation, Palatka, FL

II. Moisturization Improves skin moisture content General Recognized as Safe (GRAS) ingredients by FDA (21 CFR 184) No animal testing, non GMO.

SUMMARY OF PRODUCT CHARACTERISTICS

R&D, TESTING AND REGULATORY SERVICES TO THE PHARMACEUTICAL AND PERSONAL CARE INDUSTRIES

Extraction and refining of essential oil from Australian tea tree, Melaleuca alterfornia, and the antimicrobial activity in cosmetic products

Tea tree oil gel for mild to moderate acne; a 12 week uncontrolled, open-label phase II pilot study

ANTISEPTIC CREAM FOR USE ON THE HANDS

BIOL 251 BASIC MICROBIOLOGY

Antifungal Activity of the Essential Oil of Melaleuca alternifolia (Tea Tree Oil) against Pathogenic Fungi in vitro

Hand Care Product Systems. Your hands have been in good hands for over 60 years...

3M Hand Hygiene Solutions. Solutions that recognize what hands are up against.

Staining of the clinical material or the bacteria from colonies on laboratory media provide a direct visualization of the morphology of the organisms

Product Information Gluconolactone and Sodium Benzoate (GSB)

Range. AU-3528 Oct 16. Page 1

Development of Mangosteen Anti-Acne Gel

B & B Co., LTD Do our Best, Be the Best!

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BACTROBAN CREAM. Mupirocin Cream USP

INFECTION CONTROL SOLUTIONS

DAKTARIN. Miconazole, Miconazole nitrate CREAM, POWDER, SPRAY POWDER, LOTION, TINCTURE PRODUCT INFORMATION

The Antimicrobial Activity of Essential Oil from Perovskia abrotanoides Karel and its Main Components

Steps of microbial smear preparation :

thermal Repair Beyond the Bond ProCutiGen Thermal Shield support + protect hair cuticle ProBonding, Keratin derived biomimetic, neo-cuticle

TECHNICAL BULLETIN PURELL Waterless Surgical Scrub Technical Data

Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans

Evaluation of Cosmeceutical Ingredients: What the Label May Not Reveal Patrick Bitter, MD. Regulation of Topical Skin Care Products.

BACTROBAN CREAM QUALITATIVE AND QUANTITATIVE COMPOSITION

Sunscreen's Effects on UV Attenuation. Chase McCorkle 9 th grade Central Catholic High School

The future of disinfection is here

DO DIFFERENT WOUND DRESSINGS PROMOTE WOUND HEALING?

Innovative Preservative Solutions. Dr. Matthias Kunze LANXESS Distribution GmbH Barcelona, 16 April 2015

EXPERIMENT. Bacterial Morphology and Staining Techniques

Student Performance Guide. Student Performance Guide. Student Performance Guide

ANTIBACTERIAL ACTIVITY ASSESSMENT OF EYELINER EXTRACTED FROM NATURAL SOURCES (CASTOR OIL & SANDALWOOD)

BACTROBAN OINTMENT. Mupirocin free acid. Bacterial skin infections, e.g. impetigo, folliculitis and furunculosis.

fully a good result. However, it was not until addition of

Hand Wash. How to. IQ Hand Blue Soap. antibacterial and perfumed. Product Properties. Special Information. Environmental Information

We understand that a competitor has raised the following issues which we will address in this letter.

KILLS BACTERIA, FUNGI & VIRUSES INCLUDING: RINGWORM, STRANGLES, AVIAN FLU, MRSA, E COLI, SALMONELLA TO NAME A FEW...

Surgical Hand Scrub Updates. Surgical Hand Scrub Updates

Skin knows the difference

Candidate. Number Other Names

The Production of Capsules, Hyaluronic Acid and Hyaluronidase by Group A and Group C Streptococci

Antimicrobial Effects of Hydroxytyrosol Extracted From Olive Leaves, on Propionibacterium Acnes

new products 2015/2016

Your Solution for Infection Control. The Standard Protocol in Infection Control

Journal of Chemical and Pharmaceutical Research, 2017, 9(7): Research Article

The solution contains isopropyl alcohol 50% v/v, propylene glycol, and water.

Fluconazole for nail fungus dosage

CLINITEX A RANGE OF WIPES, CLEANSING & JANITORIAL PRODUCTS FOR HEALTHCARE PROFESSIONALS

Item/Package Details Size Item Bottle ph Shelf Life 1.0 oz/29.6 ml 1101 Lucite Matte Silver Pump months

AMINAT -G PRESERVATIVE AND ACTIVE ANTIMICROBIAL FOR COSMETICS COMPOSITION

TAKING CARE OF THE HANDS

DRS 379 RWANDA STANDARD. Aftershave Specification. First edition mm-dd. Reference number DRS 379: 2018

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory T-BACT OINTMENT. Mupirocin Ointment IP

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

COPPERPEX STICK COPPERPEX SUN

Addition of Benzylic Bromines to Ethyl Paraben. been found in studies to bind to the estrogen receptors. Because of this binding site, many

Effectiveness of Septisol Antiseptic Foam as a Surgical Scrub Agent

The simplest way to improve your indoor air quality by killing the mold, bacteria and viruses that grow in your air-conditioning system.

LOW COST HIGH QUALITY

Cashmere-derived keratin for device manufacturing on the micro- and nanoscale

A DISSERTATION SUBMITTED TO BRAC UNIVERSITY IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF BACHELOR OF SCIENCE IN MICROBIOLOGY

Infection prevention. Infection prevention. FoamING sanitizer Liquid sanitizer Foaming soap Lotion soap Lotion. EB LI, (Rev.

Formulation and Antimicrobial Activity of Triclosan- Based Conditioning Medicated Shampoo

ABOUT US. Behban pharmed lotus co. is a leading supplier. We have valid international certificates such

Unisooth EG-28 Rapid Control of Skin Irritation for the removal of Dark Circles

Therapeutics Tea tree oil reduces histamine-induced skin inflammation

Monitoring Of Antimicrobial Effect of GC-MS Standardized Melaleuca alternifolia Oil (Tea Tree Oil) On Multidrug Resistant Uropathogens

Optiblot Non-Reducing Electrophoresis Kit

Transcription:

Advance Access published July 14, 2004 Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkh359 JAC Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes Chelsea J. Longbottom 1 *, Christine F. Carson 1, Katherine A. Hammer 1, Brian J. Mee 1 and Thomas V. Riley 1,2 1 Microbiology Discipline (M502), School of Biomedical and Chemical Sciences, University of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009; 2 Division of Microbiology and Infectious Diseases, Western Australian Centre for Pathology and Medical Research, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009, Australia Received 17 February 2004; returned 18 April 2004; revised 4 June 2004; accepted 13 June 2004 Objectives: The essential oil of Melaleuca alternifolia (tea tree oil) and its components have antimicrobial activity against a wide range of Gram-positive and Gram-negative bacteria, fungi and viruses. The mechanism(s) by which Pseudomonas aeruginosa NCTC 10662 maintains a decreased susceptibility to tea tree oil and components was investigated. Results: Ethylene diamine tetraacetic acid enhanced the antimicrobial activity of tea tree oil and terpinen-4-ol against stationary phase P. aeruginosa while polymyxin B nonapeptide enhanced the activity of tea tree oil and g-terpinene. Pre-treatment with the protonophore carbonyl cyanide m-chlorophenylhydrazone increased the susceptibility of exponential phase cells to sub-inhibitory concentrations of tea tree oil, terpinen-4-ol and g-terpinene, indicating that intrinsic tolerance to tea tree oil and components is substantially energy dependent. Conclusions: Increased tolerance to tea tree oil in P. aeruginosa is directly related to the barrier and energy functions of the outer membrane, and may involve efflux systems. Keywords: terpenes, efflux, PMBN, EDTA, CCCP Introduction Tea tree oil, the essential oil obtained from the Australian native plant Melaleuca alternifolia, is composed of more than 100 terpene hydrocarbons and their associated alcohols. 1 It has broad-spectrum antimicrobial activity in vitro, making it ideal for incorporation into antiseptic creams and lotions for topical administration in cutaneous infections. A wide range of products is already available over the counter in many countries. Clinical trials using topical tea tree oil products have shown that it may be efficacious for a range of conditions including acne, 2 oral candidiasis, 3,4 herpes labialis, 5 dandruff 6 and tinea. 7 The mechanisms of antimicrobial action elucidated so far reflect the terpenic hydrocarbon composition and indicate that cytoplasmic membrane integrity is compromised by treatment with tea tree oil or some of its major components. 8,9 Alterations in eukaryotic cell membranes have also been observed with tea tree oil and terpinen-4-ol treatment. 10,11 Documented MICs of tea tree oil range from 0.06 to 0.5% (v/v) for Escherichia coli, Staphylococcus aureus and Streptococcus spp., and 2 >8% (v/v) for Pseudomonas aeruginosa. 12 15 The reduced susceptibility of P. aeruginosa to an antimicrobial is not unprecedented as this organism is frequently less susceptible to a wide range of structurally and functionally diverse antimicrobials. Several mechanisms may facilitate this reduced susceptibility, including reduced outer membrane permeability and active efflux systems. 16,17 The protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP) depolarizes the cytoplasmic membrane, and has been used to successfully demonstrate a role for efflux in both antibiotic and organic solvent resistance in P. aeruginosa. 18,19 Mann et al. 20 suggested that permeabilization of the outer membrane of P. aeruginosa with... *Corresponding author. Tel: +61-8-9346-4730; Fax: +61-8-9346-2912; E-mail: chelsea@cyllene.uwa.edu.au... Page 1 of 7 JAC q The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.

C. J. Longbottom et al. polymyxin B nonapeptide (PMBN) rendered it susceptible to g-terpinene, a component that usually exhibits little antibacterial activity. 21 While the exact mechanism of action of PMBN has not been elucidated, it is thought to bind to lipopolysaccharide (LPS) without causing its release. 22 The outer membrane permeabilizer EDTA can disrupt the integrity of the outer membrane by chelating divalent cations, resulting in the release of LPS. 22 The aim of this work was to further characterize the mechanisms responsible for the reduced susceptibility of P. aeruginosa to tea tree oil. These mechanisms may have a bearing on whether spontaneous resistance is likely to occur. Materials and methods Antimicrobial agents and chemicals Tea tree oil was produced by steam distillation and provided by Australian Plantations Pty Ltd, Wyrallah, New South Wales, Australia. The levels of components quantified according to the international standard by gas chromatography mass spectrometry 23 were as published previously 8 and included 38% terpinen-4-ol, 19.4% g-terpinene and 3.0% cineole. Terpinen-4-ol (Sigma Chemical Co., St Louis, MO, USA) and g-terpinene (Aldrich Chemical Co. Inc, Milwaukee, WI, USA) were at least 97% pure. PMBN and CCCP were purchased from Sigma. Bacteria P. aeruginosa NCTC 6749 and P. aeruginosa NCTC 10662 were obtained from the culture collection of Microbiology, University of Western Australia, Crawley, Western Australia, Australia. Time kill studies with EDTA and PMBN In preliminary experiments, the MICs of tea tree oil, terpinen-4-ol and g-terpinene for P. aeruginosa NCTC 10662 were 4%, 2% and >8% (v/v), respectively. Time kill studies were used to determine the bactericidal activity of tea tree oil, terpinen-4-ol and g-terpinene against stationary phase P. aeruginosa NCTC 10662. Tests were carried out in the presence and absence of 5 mm EDTA. Two colonies of P. aeruginosa NCTC 6749 or NCTC 10662 from overnight cultures on blood agar [5% horse blood in a Columbia agar base (Oxoid)] were inoculated into 400 ml of Mueller Hinton broth (MHB). Broths were incubated at 358C for 18 h with shaking after which stationary phase bacteria were harvested by centrifugation at 10 000 g for 10 min at 48C. The pellet was washed twice with phosphate-buffered saline (PBS; ph 7.4, NaCl 8 g/l) and suspended finally in PBS with 0.002% Tween 80 (v/v) (PBS-T). Suspensions were adjusted so that the optical density at 600 nm (OD 600 )ofa1in 100 dilution was 0.1 ± 0.01. This corresponded to 1 10 10 cfu/ml in the neat suspension. Viable counts were performed by serially diluting samples in PBS-T and spread-plating 0.1 ml samples on pre-dried nutrient agar in duplicate. After incubation at 378C for 24 h, the number of colonies was counted. For time kill studies, volumes of 8.1 ml of bacterial suspension were placed in 50 ml conical flasks. A 0.1 ml sample was removed from each flask and the concentration of organisms determined by viable count. During all time kill experiments, flasks were incubated at 358C with shaking. For tests with and without EDTA, 1 ml of 50 mm EDTA in PBS-T or 1 ml of PBS-T, respectively, was added to the flask 10 min prior to the addition of tea tree oil, terpinen-4-ol or g-terpinene. Treatment was initiated by adding 1 ml of stock concentrations of tea tree oil or components prepared earlier in PBS-T at 10-fold the final desired concentration. Tea tree oil, terpinen-4-ol and g-terpinene were tested at final concentrations of 0.125 4%, 0.06 4% and 1 2% (v/v), respectively. PBS-T was added to control flasks. The flasks were mixed for 20 s, a sample removed at 30 s and the viable count determined as above. Further samples were taken from test flasks at 30, 60, 120 and 240 min and, where rapid killing occurred, samples were also taken at 2.5, 5, 10 and 15 min. Control flasks were sampled at 120 and 240 min. There are no established inactivating agents for tea tree oil or components, so dilution was used to arrest treatment and reduce carryover as described previously. 8 The minimum dilution used was 1 in 10 and the minimum detection threshold was 3 10 3 cfu/ml. These experiments were repeated with PMBN at a concentration of 10 mg/ml replacing EDTA. Using the method described above, neither EDTA nor PMBN pre-treatment elicited bactericidal activity from g-terpinene. The results for PMBN contrasted with previous work by Mann et al. 20 Consequently, these experiments were repeated using their method with slight changes. Briefly, P. aeruginosa NCTC 6749 or P. aeruginosa NCTC 10662 was grown in Iso-Sensitest broth (Oxoid) for 18 h (yielding 1 10 9 cfu/ml) and then diluted in Iso-Sensitest broth to yield a final concentration of 1 10 6 cfu/ml. PMBN at a final concentration of 10 mg/ml was added 10 min prior to the addition of g-terpinene at a final concentration of 0.1% (v/v). Iso- Sensitest broth was added to control flasks with and without PMBN. Flasks were incubated at 358C with shaking during the experiment. Samples were taken immediately prior to treatment addition and at 0.5, 30, 60, 120 and 240 min. Samples were serially diluted and plated in duplicate to determine viable counts as described above. These experiments were repeated incorporating EDTA at 5 mm. Time kill studies with CCCP To determine whether energy-dependent processes were involved in tolerance to tea tree oil, the effect of CCCP on susceptibility to tea tree oil, terpinen-4-ol and g-terpinene was examined. In time kill experiments conducted as described above with stationary phase organisms, the addition of CCCP did not alter the bactericidal activity of tea tree oil. Since growth phase may affect susceptibility, time kill studies using exponential phase P. aeruginosa NCTC 10662 were carried out. The method used was similar to that described for experiments with EDTA and PMBN, except that exponential phase organisms were prepared. A 5 L flask was inoculated with a 6% inoculum from an overnight culture, in a final volume of 800 ml of MHB. Cells were incubated at 358C and shaken at 150 rpm on an orbital shaker for 2 h, pre-determined as early exponential phase. After harvesting and washing once in PBS, cells were resuspended in PBS-T and adjusted so that the final OD 600 of a 1 in 100 dilution was 0.1 ± 0.01. This corresponded to 1 10 10 cfu/ml in the neat suspension. These suspensions were pre-treated with 250 mm CCCP for 10 min before tea tree oil, g-terpinene or terpinen-4-ol was added. Norfloxacin was included as a positive efflux inhibition control at 3 MIC (3 mg/l). Transmission electron microscopy Stationary phase cultures of P. aeruginosa NCTC 10662 were prepared by inoculating 10 ml volumes of MHB and incubating overnight. Organisms were harvested by centrifugation for 15 min at 4000 g and the pellets resuspended in PBS-T. Suspensions of P. aeruginosa were treated with 4% (v/v) tea tree oil or 2% (v/v) terpinen- 4-ol in PBS-T for 10 or 60 min. Untreated controls in PBS-T were left on the bench for 60 min. All treatments were performed at room Page 2 of 7

Tolerance of P. aeruginosa to tea tree oil temperature. After treatment, cell suspensions were centrifuged for 15 min at 4000 g, and pellets were fixed overnight in 2.5% glutaraldehyde in 0.1 M cacodylate buffer. Fixed microbial pellets were processed in graded alcohols, propylene oxide and araldite, and cured for 48 h at 608C. Ultrathin sections were stained with uranyl acetate and lead citrate, and examined using a Philips 410 transmission electron microscope at an accelerating voltage of 80 kv. Results Figure 1. Time kill curves of stationary phase P. aeruginosa NCTC 10662 after treatment with (a and b) tea tree oil (a) cross, 0.25%; square, 0.5%; diamond, 4%; (b) triangle, 2%; diamond, 4% or (c) terpinen-4-ol: cross, 0.125%; square, 0.25%; diamond, 2%. A dotted line and open symbol indicate pre-treatment with 5 mm EDTA (a and c) or 10 mg/ml PMBN (b). A solid line indicates no pre-treatment. Control suspensions were organism alone (filled circles) and organism with EDTA or PMBN (data not shown). Results for all controls were the same. The organisms were suspended in PBS-T at 358C with shaking. Each symbol indicates the mean ± S.D. for at least three replicates. The lower detection threshold was 10 3 cfu/ml. Time kill studies with EDTA and PMBN The MIC of tea tree oil (4%, data not shown), in the absence of EDTA, reduced the number of P. aeruginosa NCTC 10662 by 3.5 log 10 in 30 min and almost 4 log 10 by 60 min (Figure 1a). Concentrations of 1% and 2% reduced the number of organisms by 2.5 log 10 over 60 min (data not shown) and the effect of 0.5% was similar. At 0.25%, there was negligible bactericidal activity. The bactericidal activity of all concentrations of tea tree oil was greatly augmented by EDTA (Figure 1a). In the presence of 0.25% tea tree oil and EDTA, viability fell below the level of detection after 30 min. For 0.5% tea tree oil and EDTA, this occurred after 20 min and, for the remaining tea tree oil concentrations, in less than 10 min. Similarly, pre-treatment with 10 mg/ml PMBN amplified the bactericidal activity of tea tree oil, but was only effective in combination with 2% or 4% tea tree oil (Figure 1b) and caused no additional cell death at lower concentrations (data not shown). In the absence of EDTA, terpinen-4-ol (MIC 2%, data not shown) reduced the viability of organisms very rapidly over the concentrations 0.25 4% (Figure 1c). A concentration of 0.25% reduced viability by 6 log 10 in 15 min although there appeared to be a 1 log 10 recovery by the end of the 4 h test period. The two lowest concentrations tested, 0.06% and 0.125%, had negligible effects on organism viability and the addition of EDTA did not alter the activity of 0.06% terpinen-4-ol (data for 0.06% terpinen-4-ol not shown). However, in the presence of EDTA, 0.125% terpinen-4-ol dramatically reduced organism viability. PMBN pre-treatment did not enhance the effect of terpinen-4-ol at 0.06% or 0.125% (data not shown). g-terpinene at 1% or 2% did not show any significant bactericidal activity against stationary phase cells of P. aeruginosa NCTC 10662 in PBS-T in the presence or absence of EDTA or PMBN (data not shown). In contrast, using the method of Mann et al., 20 0.1% g-terpinene in the presence of PMBN showed significant bactericidal activity against stationary phase cells of both P. aeruginosa NCTC 6749 and NCTC 10662 in Iso- Sensitest broth (Figure 2). After 30 min treatment with 0.1% g-terpinene, PMBN-pre-treated cells of both strains showed a 2 log 10 decrease in viability. Beyond this time-point viability fell below the limit of detection. PMBN pre-treatment alone resulted in a 1.5 log 10 decrease for NCTC 10662 and a 0.5 log 10 decrease in viability for NCTC 6749 over the 4 h treatment period. In Iso-Sensitest broth alone or Iso-Sensitest broth with 0.1% g-terpinene, the number of viable organisms increased by 1 log 10 over 4 h for both strains. When EDTA was substituted for PMBN, no sensitization to 0.1% g-terpinene was seen. The presence of EDTA tempered the growth seen in Iso-Sensitest broth alone, and the addition of 0.1% g-terpinene to EDTA-pre-treated cells failed to induce any significant bactericidal effect (Figure 2). Page 3 of 7

C. J. Longbottom et al. oil alone (Figure 3a). Similarly, treatment with 0.125% tea tree oil resulted in a 3 log 10 kill over 4 h in CCCP-pre-treated cells, compared with no cell death in cells treated with 0.125% tea tree oil only, a statistically significant difference (two-tailed Student s t-test, P = 0.003). Additional killing was not observed for treatment with tea tree oil concentrations of >_ 0.5% for CCCP-pre-treated cells. Similar experiments using 2% g-terpinene showed a 2 log 10 kill after 2 h for CCCP-pre-treated cells but no change in the viability of the cells treated with g-terpinene only (P = 0.0009) (Figure 3b). The same trend was observed with 0.1% g-terpinene. CCCP pre-treatment was also able to augment the antimicrobial effect of terpinen-4-ol (Figure 3c). A statistically significant (P = 0.0005) 1 log 10 kill over 4 h was observed in cells treated with CCCP and 0.0625% terpinen-4-ol, compared with no loss of viability in cells treated with terpinen-4-ol only. Likewise, treatment with 0.125% terpinen-4-ol caused an additional 0.7 log 10 kill in CCCP-pre-treated cells compared with control cells (P = 0.04). Figure 2. Time kill curves of stationary phase P. aeruginosa NCTC 10662 (a) or P. aeruginosa NCTC 6749 (b) in Iso-Sensitest broth (filled circles), and after treatment with 0.1% g-terpinene alone (filled triangles), pre-treatment with 10 mg/ml PMBN (filled diamonds, long dotted line) or 5 mm EDTA alone (filled squares, long dotted line), or treatment with 0.1% g-terpinene combined with pre-treatment with PMBN (open diamonds, short dotted line) or EDTA (open squares, short dotted line). Each symbol indicates the mean ± S.D. for at least three replicates. The lower detection threshold was 10 3 cfu/ml. Time kill studies with CCCP Exponential phase P. aeruginosa NCTC 10662 cells were more susceptible to the antimicrobial action of tea tree oil than stationary phase cells. Cells treated with 250 mm CCCP alone did not show a decline in viability over the 4 h treatment period (data not shown). Bactericidal activity against cells pre-treated with CCCP and subsequently exposed to 2 or 3 MIC of norfloxacin (an antibiotic known to be effluxed from P. aeruginosa) was greater than that in the norfloxacin-only control after 2 h (data not shown). This indicated that depolarizing the cell membranes with CCCP sensitized the organisms to norfloxacin, possibly by inhibiting the function of efflux pumps. The addition of 0.25% tea tree oil to CCCP-pre-treated cells resulted in a 3 log 10 kill after 4 h, compared with a 0.7 log 10 kill with 0.25% tea tree Transmission electron microscopy P. aeruginosa cells treated for 60 min with terpinen-4-ol contained many electron-sparse inclusions (Figure 4a) while those treated for 10 min (not shown) and control cells had none (Figure 4b). Perturbations of the outer membrane, but no inclusions, were observed in tea-tree-oil-treated cells (Figure 4c). Discussion Pseudomonas spp. have decreased susceptibility to tea tree oil compared with other bacterial species, and the mechanisms involved may have a bearing on the spontaneous development of resistance. Many of the components of tea tree oil have antimicrobial activity and it is possible that tea tree oil has multiple mechanisms of action. If so, spontaneous resistance may be less likely to occur. In this study, the antimicrobial activity of tea tree oil and/or components against P. aeruginosa was investigated in the presence of two outer membrane permeabilizers, EDTA and PMBN. The pre-treatment of stationary phase cells in PBS with EDTA rendered cells more vulnerable to the bactericidal properties of tea tree oil and terpinen-4-ol but not g-terpinene. Similarly, PMBN pre-treatment rendered cells more vulnerable to the bactericidal effect of tea tree oil but not to terpinen-4-ol or g-terpinene. The enhanced activity in the presence of EDTA or PMBN suggests that one or more target sites for tea tree oil and/or terpinen-4-ol lie within the cell. The initial failure of either EDTA or PMBN to enhance the activity of g-terpinene was in contrast to the findings of Mann et al. 20 However, using the method they described, g-terpinene combined with PMBN had considerable bactericidal activity. While this is likely to be due to permeabilization, the activity of PMBN alone cannot be disregarded (see Figure 2) as PMBN has been reported to inhibit the growth of P. aeruginosa. 24,25 Interestingly, the bactericidal activity of g-terpinene and PMBN was seen in Iso-Sensitest broth but not in buffer. The contrast in activity is noteworthy since there was little difference between the two methods apart from the medium used, suggesting that the permeabilization effect of PMBN or the bactericidal activity of g-terpinene may require growth and an active metabolic state. Also noteworthy was the failure of EDTA to elicit bactericidal activity from g-terpinene using either method. Page 4 of 7

Tolerance of P. aeruginosa to tea tree oil Figure 4. Electron micrographs of P. aeruginosa NCTC 10662 cells treated with 2% terpinen-4-ol for 60 min (a), 4% tea tree oil for 10 min (c) or after no treatment (60 min) (b). Magnifications: (a) 14400; (b) 11700; and (c) 10800. Pre-treatment of P. aeruginosa with the electron-transport inhibitor CCCP resulted in increased susceptibility to otherwise sub-inhibitory concentrations of tea tree oil (0.125% and 0.25%), an effect that has also been shown in eukaryotic cells. 11 Clearly, an energy-dependent process is involved in tolerance to tea tree oil. However, pre-treatment with CCCP followed by R Figure 3. Time kill curves of exponential phase P. aeruginosa NCTC 10662 treated with (a) tea tree oil: filled triangles, 0.125%; crosses, 0.25%; filled squares, 0.5%; (b) g-terpinene: filled triangles, 0.1%; filled diamonds, 2%; or (c) terpinen-4-ol: filled triangles, 0.0625%; crosses, 0.125% with (open symbol, dotted line) or without (filled symbol, solid line) 250 mm CCCP pre-treatment. CCCP pre-treatment alone had no bactericidal activity (data not shown). The organisms were suspended in MHB-T. Each symbol indicates the mean ± S.D. for at least three replicates. The lower detection threshold was 10 3 cfu/ml. Page 5 of 7

C. J. Longbottom et al. treatment with 0.5% or 1% tea tree oil had no additional bactericidal effect, suggesting that once a certain threshold is reached, the mechanisms that facilitate tolerance at low levels are overwhelmed. The component g-terpinene is frequently regarded as antimicrobially inactive. 20,21 This work shows that PMBN or CCCP pre-treatment unmasks the antimicrobial activity of g-terpinene, presumably by compromising various membrane barrier functions. Multi-drug efflux systems of P. aeruginosa, in particular the MexAB OprM system, have been associated with intrinsic tolerance to organic solvents. 18 Our results with CCCP suggest that energy-dependent processes, possibly efflux systems, are involved in the resistance of P. aeruginosa cells to g-terpinene. Experiments with reserpine, a known inhibitor of efflux in Gram-positive 26,27 and some Gram-negative 28,29 bacteria, were unsuccessful since reserpine did not inhibit the efflux of norfloxacin by P. aeruginosa NCTC 10662 in positive controls (data not shown). Further support for the role of efflux systems comes from the multiple, prominent electron-sparse inclusions seen in terpinen- 4-ol-treated cells by electron microscopy. It is possible that they are globules of terpinen-4-ol that have accumulated in the cell due to efflux malfunction. However, their identity was not characterized further and this inference remains speculative. Extracellular electron-dense blebs and loss of cytoplasmic material have been observed in tea-tree-oil-treated E. coli 30 and S. aureus, 8 respectively. No blebbing or loss of electron-dense material was observed in either tea-tree-oil- or terpinen-4-oltreated P. aeruginosa cells but perturbations of the outer membrane were observed in tea-tree-oil-treated cells. P. aeruginosa is an important opportunistic pathogen well known for its resistance to conventional antimicrobials. Given the impact of this resistance, alternative antibacterial agents have long been sought, including those for topical treatment. This work has reiterated the role of the outer membrane in protecting P. aeruginosa against tea tree oil and components, and has shown that energy-dependent processes are involved in this increased tolerance. The role that efflux may play in this increased tolerance is currently being investigated. Acknowledgements We thank Dr Terry Robertson, Pathology, University of Western Australia for assistance with the electron microscopy. This work was supported by Novasel Australia Pty Ltd and grant UWA79A from the Rural Industries Research and Development Corporation, Canberra, Australian Capital Territory, Australia. References 1. Brophy, J. J., Davies, N. W., Southwell, I. A. et al. (1989). Gas chromatographic quality control for oil of Melaleuca terpinen-4-ol type (Australian tea tree). Journal of Agricultural and Food Chemistry 37, 1330 5. 2. Bassett, I. B., Pannowitz, D. L. & Barnetson, R. St C. (1990). A comparative study of tea tree oil versus benzoylperoxide in the treatment of acne. Medical Journal of Australia 153, 455 8. 3. Jandourek, A., Vaishampayan, J. K. & Vazquez, J. A. (1998). Efficacy of Melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 12, 1033 7. 4. Vazquez, J. A. & Zawawi, A. A. (2002). Efficacy of alcoholbased and alcohol-free Melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. HIV Clinical Trials 3, 379 85. 5. Carson, C. F., Ashton, L., Dry, L. et al. (2001). Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. Journal of Antimicrobial Chemotherapy 48, 450 1. 6. Satchell, A. C., Saurajen, A., Bell, C. et al. (2002). Treatment of dandruff with 5% tea tree oil shampoo. Journal of the American Academy of Dermatology 47, 852 5. 7. Satchell, A. C., Saurajen, A., Bell, C. et al. (2002). Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Australasian Journal of Dermatology 43, 175 8. 8. Carson, C. F., Mee, B. J. & Riley, T. V. (2002). Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time kill, lysis, leakage, and salt tolerance assay and electron microscopy. Antimicrobial Agents and Chemotherapy 46, 1914 20. 9. Cox, S. D., Mann, C. M., Markham, J. L. et al. (2000). The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). Journal of Applied Microbiology 88, 170 5. 10. Calcabrini, A., Stringaro, A., Toccacieli, L. et al. (2004). Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells. Journal of Investigative Dermatology 122, 349 60. 11. Hammer, K. A., Carson, C. F. & Riley, T. V. (2004). Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. Journal of Antimicrobial Chemotherapy 53, 1081 5. 12. Banes-Marshall, L., Cawley, P. & Phillips, C. A. (2001). In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. British Journal of Biomedical Science 58, 139 45. 13. Beylier, M. F. (1979). Bacteriostatic activity of some Australian essential oils. Perfumer and Flavourist 4, 23 5. 14. Carson, C. F., Hammer, K. A. & Riley, T. V. (1995). Broth microdilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil). Microbios 82, 181 5. 15. Hammer, K. A., Carson, C. F. & Riley, T. V. (1999). Antimicrobial activity of essential oils and other plant extracts. Journal of Applied Microbiology 86, 985 90. 16. Li, X. Z., Livermore, D. M. & Nikaido, H. (1994). Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrobial Agents and Chemotherapy 38, 1732 41. 17. Nakae, T., Nakajima, A., Ono, T. et al. (1999). Resistance to b-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB OprM efflux pump and b-lactamase. Antimicrobial Agents and Chemotherapy 43, 1301 3. 18. Li, X., Zhang, L. & Poole, K. (1998). Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. Journal of Bacteriology 180, 2987 91. 19. Li, X., Nikaido, H. & Poole, K. (1995). Role of MexA MexB PorM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 39, 1948 53. 20. Mann, C. M., Cox, S. D. & Markham, J. L. (2000). The outer membrane of Pseudomonas aeruginosa NCTC 6749 contributes to its tolerance to the essential oil Melaleuca alternifolia (tea tree oil). Letters in Applied Microbiology 30, 294 7. 21. Carson, C. F. & Riley, T. V. (1995). Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. Journal of Applied Bacteriology 78, 264 9. 22. Vaara, M. (1992). Agents that increase the permeability of the outer membrane. Microbiological Reviews 56, 395 411. 23. International Organization for Standardization. (1996). Essential oils oil of Melaleuca, terpinen-4-ol type (tea tree oil). Page 6 of 7

Tolerance of P. aeruginosa to tea tree oil ISO-4730. International Organization for Standardization. Geneva, Switzerland. 24. Vaara, M. & Vaara, T. (1983). Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature 303, 526 8. 25. Viljanen, P. & Vaara, M. (1984). Susceptibility of Gram-negative bacteria to polymyxin B nonapeptide. Antimicrobial Agents and Chemotherapy 25, 701 5. 26. Kaatz, G. W. & Seo, S. M. (1997). Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 41, 2733 7. 27. Markham, P. N. (1999). Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine. Antimicrobial Agents and Chemotherapy 43, 988 9. 28. Miyamae, S., Nikaido, H., Tanaka, Y. et al. (1998). Active efflux of norfloxacin by Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 42, 2119 21. 29. Valdezate, S., Vindel, A., Echeita, A. et al. (2002). Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrobial Agents and Chemotherapy 46, 665 71. 30. Gustafson, J. E., Liew, Y. C., Chew, S. et al. (1998). Effects of tea tree oil on Escherichia coli. Letters in Applied Microbiology 26, 194 8. Page 7 of 7